Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
Titel:
Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
Auteur:
Liang, Ke Esteva, Francisco J. Albarracin, Constance Stemke-Hale, Katherine Lu, Yang Bianchini, Giampaolo Yang, Ching-Yi Li, Yong Li, Xinqun Chen, Chun-Te Mills, Gordon B. Hortobagyi, Gabriel N. Mendelsohn, John Hung, Mien-Chie Fan, Zhen